LY3214996 is primarily used in research settings to study its potential therapeutic effects, particularly in the context of cancer treatment. It functions as an inhibitor of specific signaling pathways that are often dysregulated in various cancers, making it a valuable tool for understanding tumor growth and progression. Researchers utilize this compound to explore its efficacy in halting the proliferation of cancer cells and to assess its potential as a targeted therapy. Additionally, it is employed in preclinical studies to evaluate its safety profile and pharmacokinetics, which are critical steps in the development of new anticancer drugs. Its application extends to investigating combination therapies, where it may be used alongside other agents to enhance treatment outcomes. Overall, LY3214996 serves as a promising candidate in the ongoing search for more effective cancer treatments.